Spatial Biology – News and Features

Collaboration on immuno-oncology combination clinical trial.

A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.

Collaboration to Focus on Cancer Immunotherapy Combination of Peregrine's PS-Targeting Bavituximab and AstraZeneca's PD-L1 Inhibitor MEDI4736.

A new statistical method for analyzing next-generation sequencing (NGS) data that helps researchers study the genome of various organisms such as human tumors and could help bring about personalized cancer treatments has been unveiled.

Einstein-Montefiore investigators build upon their tumor microenvironment research.

The companies are set to enter into an agreement to develop novel immuno-oncology treatments for a range of cancers.

The study aims to understand how lung cancers mutate, adapt and become resistant to treatments.

Combination aims to achieve high levels of activation of CART cells in tumors with reduced toxicity in normal tissues.

Scientists report that two different mouse models of breast cancer progressed differently based on characteristics of the tumor microenvironment, which is the area of tissue in which the tumor is embedded.

Engineered probiotics can detect tumors in the liver.